How ChrysCapital’s partial exit from drugmaker panned out

Premium

ChrysCapital has sold another chunk of its stake in a Mumbai-based drugmaker, as the homegrown private equity firm positions itself to exit the seven-year-old investment by taking advantage of a buoyant stock market. The PE firm recently sold 1.2 million shares, or nearly a 1% stake, in Ipca Laboratories Ltd through ......